Form 4 for DGX Quest Diagnostics
Accepted 2023-02-27 00:00:00 ET · period of report 2023-02-23 · accession 0001022079-23-000038 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-27 | 2023-02-23 | DGX | Davis J. E. | CEO, Pres, Dir | A - Grant | $0.00 | +17.4K | 96.8K | +22% | $0 |
| D | 2023-02-27 | 2023-02-23 | DGX | Davis J. E. | CEO, Pres, Dir | F - Tax | $147.86 | -1,473 | 79.3K | -2% | -$217.8K |
| D | 2023-02-27 | 2023-02-23 | DGX | Davis J. E. | CEO, Pres, Dir | A - Grant | $0.00 | +69.0K | 69.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-23 | A | A | 17,443 | $0.00 | 96,758 | D | — | — | (F2) Represents an award of restricted share units. |
| 2 | Common | Common Stock | 2023-02-23 | F | D | 1,473 | $147.86 | 79,315 | D | — | — | (F1) Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units. |
| 3 | Derivative | Non-Qualifed Stock Option (right to buy) | 2023-02-23 | A | A | 68,956 | $0.00 | 68,956 | D | $143.33 · — to 2033-02-23 | 68,956 Common Stock | (F3) The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. |